Results 201 to 210 of about 300,691 (256)

Immune Aging Within the Tumor Microenvironment Predicts Survival in Lung Adenocarcinoma. [PDF]

Cancers (Basel)
Kim T, Choi H, Jang TW, Oak CH.
europepmc   +1 more source

A comprehensive analysis of palmitoylation related genes in lung adenocarcinoma. [PDF]

Discov Oncol
Jiang J, Li Z, Yan T, He Y, Zhu J, Jin X, Rao S, Rao X.   +7 more
europepmc   +1 more source

Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma‐based collection of 77 patients with locally advanced unresectable esophageal cancer

International Journal of Cancer, EarlyView.
What's New? This study introduces a novel approach for detecting locally advanced esophageal carcinoma using cell‐free DNA (cfDNA) analysis through a highly sensitive fragmentome assay. Unlike traditional sequencing‐based methods that are limited by the absence of specific mutations in esophageal tumors, our method offers an alternative by quantifying ...
Anouchka Modesto, Sophie Gibert, Caroline Delmas, David Tougeron, Amaury Paumier, Alexandre Taillez, Samuel Le Sourd, Delphine Argo Leignel, Philippe Ronchin, Ariane Darut Jouve, Véronique Vendrely, Olivier Riou, Jérôme Martin‐Babau, Thomas Leroy, Laurent Quéro, Naïma Hanoun, Pierre Cordelier, Veronica Pezzella, Jean Pierre Delord, Rosine Guimbaud, Elizabeth Moyal, Catherine Seva   +21 more
wiley   +1 more source

CLWD: a Chinese histopathology dataset for lung adenocarcinoma subtype classification. [PDF]

Sci Data
Chen Y, Zhao H, Wang L, Li L, Liu R, Jiang Y, Tang P, Li Y, Ni J, Tao D, Li J, Peng J.   +11 more
europepmc   +1 more source

Lung adenocarcinoma

, 2016
openaire   +1 more source

Gene signatures characterizing driver mutations in lung squamous carcinoma are predictive of the progression of pre‐cancer lesions

International Journal of Cancer, EarlyView.
What's New? Lung squamous cell carcinoma (LUSC) is more aggressive than lung adenocarcinoma, and is most often diagnosed at an advanced stage. Here, the authors evaluated gene expression data from LUSC tumors and came up with gene signatures for 34 genetic abnormalities whose expression changes throughout different precancerous stages. Several of these
Yupei Lin, Venugopalareddy Mekala, Jianrong Li, Xiang Wang, Muhammad Aminu, Jia Wu, Jianjun Zhang, Robert Taylor Ripley, Christopher I. Amos, Chao Cheng   +9 more
wiley   +1 more source

Neovascular Glaucoma Secondary to Choroidal Metastasis From Lung Adenocarcinoma: A Palliative Management Challenge. [PDF]

Cureus
Mohamad Kani NH, Lam C, Othman O.
europepmc   +1 more source

Amivantamab Monotherapy for Lung Adenocarcinoma With Leptomeningeal Seeding: A Case Report. [PDF]

Respirol Case Rep
Park K, Kim SY, Um SW.
europepmc   +1 more source

FGF2 as a Potential Tumor Suppressor in Lung Adenocarcinoma. [PDF]

Diagnostics (Basel)
Lin SS, Lu HY, Chang TM, Sun YS, Liu JF.
europepmc   +1 more source

Therapeutic potential of targeting MASTL in lung adenocarcinoma. [PDF]

Sci Rep
Liu J, Li J, Luo J, Jiang Y, Hu H, Zhu L, Li Y, Xiao ZJ.   +7 more
europepmc   +1 more source